Fysicon B.V. has been acquired by Canon Medical Systems
March 2018 — Canon Medical Systems Corporation, a Japan-based developer of medical diagnostic imaging systems and medical solutions, has acquired Fysicon B.V., a developer of healthcare information systems in the Netherlands, for an undisclosed consideration.
Fysicon is a developer and assembler of innovative medical software and hardware for hospitals, clinics and research institutes. Since its foundation in 1996 and with unique advanced technologies and clinical evidence, Fysicon has developed and manufactured product families such as cardiovascular monitoring systems. Fysicon's CEO Linda Elberse, said: "Now we are ready to take our business to the next level, and we truly appreciate the Dutch team's role in helping to make it happen."
Canon Medical Systems Corporation develops medical diagnostic imaging systems and medical solutions. It offers angiography, computed tomography, magnetic resonance, ultrasound, X-ray, nuclear medicine, healthcare imaging informatics systems and RF amplifier components. The company was founded in 1930 and is headquartered in Otawara-shi, Japan, with subsidiaries in Japan, North America, South America, Europe, Africa, the Mid-East, Asia, and Oceania.
Our role in the transaction
Oaklins' healthcare team in the Netherlands advised the selling shareholder throughout the process.
Talk to the deal team
Related deals
Katalyst Diagnostics has been acquired by Cruinn Diagnostics
Katalyst Diagnostics Ltd. has been acquired by Cruinn Diagnostics Ltd. The acquisition strengthens Cruinn Diagnostics’ presence in the UK diagnostics market, adding established NHS customer relationships, local commercial infrastructure and a complementary portfolio of point-of-care diagnostic solutions. It also creates opportunities to introduce Cruinn Diagnostics’ products to UK customers while leveraging its established Irish platform to accelerate the growth of Katalyst Diagnostics’ portfolio in Ireland. With more than 100 employees and revenues in excess of US$56 million, the combined business will continue to focus on the UK market, where Cruinn Diagnostics sees significant opportunities to expand through further investment and targeted M&A.
Learn moreLife & Mobility has attracted investor Bolster Investment Partners
Life & Mobility, a leading developer and manufacturer of premium mobility and rehabilitation solutions, has welcomed Bolster Investment Partners as a new shareholder. The partnership provides Life & Mobility with a strong long-term partner to support the company’s next phase of growth, with a continued focus on product innovation, strengthening its leading market position and further international expansion. The company’s mission remains to enhance the mobility, independence and quality of life of end users through innovative, sustainable and circular mobility solutions designed for multiple life cycles.
Learn moreSynergia and Bolster have secured acquisition financing for Life & Mobility
Synergia Capital Partners and Bolster Investment Partners have partnered with Life & Mobility, a leading Dutch developer and manufacturer of premium mobility and rehabilitation solutions. The partnership marks an important next step in Life & Mobility’s growth trajectory, focused on further international expansion, continued product innovation and strengthening its leading market position.
Learn more